Bodal Chemicals Approves Q1 FY27 Standalone & Consolidated Results; AGM on Sept 25
Bodal Chemicals declared standalone and consolidated unaudited financial results for Q1 FY27. Standalone revenue was ₹698.29 crore, with profit after tax at ₹287.83 crore. Consolidated revenue stood at ₹709.04 crore, with profit after tax at ₹303.79 crore. The company also announced its Annual General Meeting will be held on September 25, 2026.
The announcement includes the declaration of quarterly financial results, which is a material event for investors. The scheduling of the AGM is also a significant corporate event.
The announcement reports financial results and upcoming corporate events. While the results themselves are factual, there is no explicit positive or negative commentary within the provided text to sway the sentiment.
Bodal Chemicals Limited announced the outcome of its Board Meeting held on August 5, 2026. The Board approved and declared the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. The company also appointed M/s Tapan Shah, Practicing Company Secretary, as the Scrutinizer for the e-voting process for the upcoming Annual General Meeting (AGM).
The AGM of the Company is scheduled to be held on Friday, September 25, 2026, through Video Conferencing (VC) or Other Audio Visual Means (OAVM).
For the quarter ended June 30, 2026, the standalone revenue from operations was ₹698.29 crore, with a total income of ₹703.57 crore. The profit before tax stood at ₹387.41 crore, and the profit for the period was ₹287.83 crore. The basic and diluted earnings per share were ₹2.29.
On a consolidated basis, the revenue from operations for the quarter ended June 30, 2026, was ₹709.04 crore, with a total income of ₹715.18 crore. The profit before tax was ₹391.20 crore, and the profit for the period was ₹303.79 crore. The basic and diluted earnings per share were ₹2.41.
The company's financial results were reviewed by M/s. B N P S & Associates LLP, Statutory Auditors.
What to do with a filing like this
Bodal Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Bodal Chemicals Limited. Read the original for the full detail.